The Laboratory for Molecular Medicine at Partners Healthcare has released its Pan-Cardiomyopathy Panel, a 46-gene sequencing based test for cardiomyopathy (CSN 5/11/2011). The test combines gene panels for hypertrophic cardiomyopathy, dilated cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy, and also adds 16 new genes. The test is performed using Agilent's SureSelect oligonucleotide-based target capture and sequencing on the Illumina HiSeq 2000.
New Products: Jul 27, 2011
Jul 28, 2011